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Abstract
Background:  Thus far important findings regarding the dementia syndrome have been
implemented into patients' medical care only inadequately. A professional training accounting for
both, general practitioners' (GP) needs and learning preferences as well as care-relevant aspects
could be a major step towards improving medical care. In the WIDA-study, entitled "Knowledge
translation on dementia in general practice" two different training concepts are developed,
implemented and evaluated. Both concepts are building on an evidence-based, GP-related dementia
guideline and communicate the guideline's essential insights.
Methods/Design: Both development and implementation emphasize a procedure that is well-
accepted in practice and, thus, can achieve a high degree of external validity. This is particularly
guaranteed through the preparation of training material and the fact that general practitioners'
quality circles (QC) are addressed. The evaluation of the two training concepts is carried out by
comparing two groups of GPs to which several quality circles have been randomly assigned. The
primary outcome is the GPs' knowledge gain. Secondary outcomes are designed to indicate the
training's potential effects on the GPs' practical actions. In the first training concept (study arm A)
GPs participate in a structured case discussion prepared for by internet-based learning material
("blended-learning" approach). The second training concept (study arm B) relies on frontal medical
training in the form of a slide presentation and follow-up discussion ("classical" approach).
Discussion: This paper presents the outline of a cluster-randomized trial which has been peer
reviewed and support by a national funding organization – Federal Ministry of Education and
Research (BMBF) – and is approved by an ethics commission. The data collection has started in
August 2006 and the results will be published independently of the study's outcome.
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Background
Dementia is a highly prevalent syndrome in industrial
nations. In Germany, due to demographic developments,
an increase of dementia patients can be expected. Accord-
ing to estimations, only 20% of all persons with dementia
are adequately treated in Germany [1-4]. It seems that
shortcomings in professional education and training, par-
ticularly among general practitioners (GPs) are one of the
reasons for this deficiency in medical care [2-5]. Findings
indicate that GPs frequently feel awkward about having to
communicate with patients and their relatives about diag-
nosis "dementia" and therefore do not make a serious
attempt at diagnosis [6-9]. In order to overcome these bar-
riers, it is necessary to develop and evaluate appropriate
instruments suited to sustainable supporting GPs' knowl-
edge and competence in dealing with the dementia syn-
drome and therefore to improving medical care.
For this purpose, two training concepts have been devel-
oped in the WIDA-study which will be implemented in
GP quality circles:
1. In study concept A, GPs participate in a structured case
discussion in the context of quality circles. The structured
discussion is prepared by the GPs in advance via internet-
based learning material ("blended-learning" approach).
2. In study concept B, participants are instructed in a clas-
sical way with an oral presentation. A structured discus-
sion of the subject matters follows the presentation of the
instructor ("classical" approach).
Both training concepts communicate the essential points
of an evidence-based guideline on diagnosis and treat-
ment of dementia focusing on GPs. The effects of the two
concepts are compared in a cluster randomized controlled
study. In addition possible barriers of implementation
will be identified.
Dementia
The term dementia describes an etiologically heterogene-
ous clinical syndrome characterized by the loss of intellec-
tual and mnestic abilities. Depending on etiology,
dementia-related syndromes can be found in any stage of
life. However, they generally show a continuously increas-
ing prevalence in the 60+ age groups. While for those aged
65–69 incidence is below 2%, there is a rise to a 10–17%
incidence for those aged 80–84; for those over 90 the inci-
dence reaches 30% [10].
The most frequently occurring dementia-related forms are
￿ the so-called degenerative forms, particularly dementias of
the Alzheimer's type,
￿ followed by vascular dementias due to ischemically
caused destruction of brain tissue and
￿ mixed degenerative-vascular forms of dementia.
Alzheimer's dementia tends to display no physical or neu-
rological symptoms in the first years. Cognitive malfunc-
tions generally manifest themselves in the form of a
progressive reduction of short-term memory, orientation
ability and word-finding difficulties. Complex daily tasks
can no longer be accomplished. Typically, there is a creep-
ing onset of the disease, which initially proceeds slowly.
The intermediary stage is characterized by a disfunction-
ing of the long-term memory and the patients' ability to
think clearly. Patients are no longer able to work in their
vocation and cannot manage their household. Apart from
this, non-cognitive disorders such as agitation, irritability,
emotional instability or aggression, and even apathy and
depression can occur. Moreover, a urinary incontinence
(aconuresis) can frequently be detected. The late stage of
Alzheimer's disease is characterized by profound intellec-
tual degeneration and comprehensive need for nursing
care due to symptoms such as complete urinary and anal
incontinence, impaired movement, inability to control
posture, cerebral convulsions, and swallowing disfunc-
tionality. Dementia patients normally spend the late
stages of the disease in a nursing home.
Further facts about the dementia syndrome:
￿ Presently there are about one million persons suffering
from dementia in Germany [5,11,12]; among them
approximately 700,000 suffer from Alzheimer's disease
[11,12]. More than 200,000 new cases of dementia are
reported each year, 125,000 of which can be attributed to
Alzheimer's disease. Projections which consider demo-
graphic developments predict that the number of demen-
tia patients will increase to more than 2 millions by 2050
in Germany [11,12].
￿ As a general rule, dementia displays a chronically pro-
gressive development: beginning with the first disease-
related symptoms, the average survival period is eight to
nine years. According to more recent studies, the median
survival time following clinical diagnosis is 4.2 years for
men and 5.7 years for women [13,14]. A Canadian study
even indicates a median survival time of just 3.3 years
after clinical diagnosis [15].
￿ Dementia has far-reaching consequences for both the
patient and his or her relatives: Apart from the loss of
autonomy and an increasing need for nursing care,
dementia patients frequently suffer from malnutrition or
undernourishment and an increased susceptibility to
infection. Persons with dementia also display a greaterBMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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risk of contracting pneumonia, seizure disorders, or pres-
sure ulcers [5,16]. Furthermore, there is a heightened risk
of accident as well as an increased risk of becoming a vic-
tim of crime [5].
￿ In most cases, negative consequences for the social envi-
ronment surface quite rapidly; caregivers and relatives of
persons with dementia often suffer from a high degree of
physical and mental stress [5,17].
￿ Dementia is one of the most costly diseases [17,18].
There are only a few current studies on the costs of demen-
tia treatment in Germany. However, their results are com-
parable to those found in international studies [11,18].
For the year 2002, the Federal Office of Statistics assumed
that costs amounted to as much as € 5.6 ($ 7.3) billion,
with 60% of the total costs incurred for in-patient or par-
tially stationary care [19].
￿ There are many reasons for the above-mentioned prob-
lems in the treatment of dementia. [2,5,20]:
 Either the acknowledgement of dementia is considered
taboo or dementia is classified as a form of aging.
 Knowledge of diagnostic procedures and adequate treat-
ment is deficient.
 Diagnosis mostly occurs in the advanced stages of the
disease.
 Many nursing homes are not prepared to treat individu-
als with dementia and/or have a shortage of staff.
 People with dementia naturally have a hard time articu-
lating their discomfort and wishes.
 A comprehensive therapeutic approach does not exist.
 Newly-developed drugs are too expensive (limited
health care budgets); the effectiveness is controversially
judged and therefore they are only reservedly prescribed.
 Further education and training programs in the medical pro-
fession are inadequate.
Perspective of General Practice
Dementia is a syndrome that typically occurs in general
medicine even though the setting of general practice is
only rarely considered in the literature [6-9,21-33]. Wag-
ner and Abholz stated:" The medical and psychosocial
care of people with dementia lies largely in the hands of
GPs. The GP knows the patient, his or her relatives, and
the social setting. Therefore, s/he is in the best position to
notice even slight changes of intellectual perform-
ance"[7]. The same publication points out that GPs – due
to the lack of therapeutic consequences – do not seriously
wish to diagnose the illness. Moreover, there is evidence
that GPs feel awkward about having to talk with patients
about such an emotionally charged diagnosis [6-8,33]. A
study carried out in Wales and England with more than
1,000 GPs found that only 52% of all respondents consid-
ered early diagnosis to be useful [34]. A 1992 Australian
study observed only marginal knowledge of dementia on
the part of primary care practitioners [35]. In Germany,
GPs frequently diagnose dementia only when the need of
nursing care already exists [36].
A summary of various studies shows that GPs either lack
knowledge and professional skills in the treatment of
dementia or do not make use of their existing knowledge
when treating their patients.
Guidelines
Field and Lohr define clinical practice guidelines (CPGs)
as "systematically developed decision support regarding
the adequate medical modus operandi for special health-
related problems"[37]. Moreover, the following aspects
are relevant [38]:
￿ Guidelines present the consensus reached by several
experts from diverse faculties and working groups on cer-
tain medical approaches (if possible by considering the
patients' view).
￿ Guidelines are scientifically founded recommendations
for action.
￿ Methodological instruments for creating guidelines are
(among others): consensus conferences, Delphi analyses,
therapeutic studies, and meta-analyses.
￿ Guidelines are orientation aids in the sense of "guide-
lines for action and decision making". In some cases
divergence from the guideline is possible or even essen-
tial.
￿ Guidelines are regularly checked and updated if neces-
sary.
Evidence-based medical guidelines are considered to be
the central implementation tool for evidence-based med-
icine (EbM). In this capacity they can also serve as a basis
for further professional education and training [39-43].
Various strategies for implementing guidelines, including
electronic guidelines, have been evaluated [44,45,80].
However, no strategies have been identified which, in all
circumstances, will result in a successful implementation
of new knowledge or in the desired behavioral changes
[46,47]. A Health Technology Report (HTA) published inBMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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2004 states that " [...] despite 30 years of research in this
area, we still lack a robust generalisable evidence base to
inform decisions about strategies to promote the intro-
duction of guidelines or other evidence-based messages
into practice" [48].
Continuing medical education and knowledge translation
The German Society for General and Family Medicine
(DEGAM) has identified general deficits in the profes-
sional training of GPs. A statement stresses: "From the
point of view of general practitioners, the current situa-
tion in the field of further education is a discontenting
one, characterized by outdated didactical methods, insuf-
ficient consideration of individual learning requirements,
and an overemphasized focus on specialized disciplines
as well as on the interests of the pharmaceutical industry"
[49]. Worldwide there are efforts to improve the further
education of GPs. Studies indicate that roughly one third
of all changes in clinical practice are related to further edu-
cation and training [50]. In this regard, a shift from "con-
tinuing medical education (CME)" to "continuing
professional development (CPD)" can be detected [51-
55]. Professional development is characterized by meth-
odological variety and a diverse curriculum which
attempts to consider the various preferences and types of
learning. The methods also include the formative or sum-
mative assessment of acquired competences. "Stand-
alone" CME programs seem to be less successful than pro-
grams with multi-modal interventions [47,56-58].
The "new media" are clearly gaining relevance within
standard curricula. Electronic programs are being used for
knowledge translation as well as knowledge assessment
[59-63]. Data suggest that online-training may even result
in a change of the GPs' behavior [62,64]. Problem-ori-
ented learning via internet may also provide another
promising option [65]. If students are accustomed to this
form of learning, positive experiences made during the
university education may be transferred to continuing
education [66-68].
"Blended learning", which blends the features of classical
or ex-cathedra teaching with those of e-learning, marks
the threshold to a new concept of further education in the
field of medicine [60,66,69,70]. "Blended learning is
based on the recognition that a learning system based
purely on electronic learning can only offer limited effi-
ciency. Therefore blended learning combines e-learning
with standard teaching methods or, rather, various teach-
ing/learning media. Course content is conveyed face-to-
face as well as via WBT (web based training), CD-Rom or
print media. Learners are not bound to a specific medium.
Instead they have the option of choosing a medium with
suits their individual learning preferences. Thus blended
learning involves the merging of e-learning/teaching with
classical forms of learning/teaching, with the goal of pro-
viding an optimal overall concept" [71].
Strategies for applying the relatively new tools of e-learn-
ing to medicine have yet to be developed [46]. In order to
do so, the needs of the users should first be analyzed. In
addition, it should also be clarified what they want to
learn and how they want to learn [8,38]. Suitable instru-
ments need to be developed for this purpose. Only then
we will be able to develop efficient (online) CME and
CPD programs that implement sustainable, evidence-
based guidelines respectively new knowledge and lead to
an improvement of medical care. In this respect, a large
need for research has been identified.
As a first step, it is important to clarify how doctors learn
and make sure that their knowledge and skills are up-to-
date. The following questions serve to determine this [40]:
(1) "Which educational interventions work in which situ-
ations?"
(2) "What factors promote the adoption of guidelines?"
(3) "Which factors inhibit their adoption?" (Authors note:
barrier analysis)
(4) "What type of physician learning happens at what
stages?"
The goal of the WIDA study is to compare the blended-
learning concept with conventional training methods in
order to assess whether the new concept can lead to an
improved knowledge translation of dementia-related
methods of diagnosis and treatment.
Study goals
WIDA seeks to achieve the following goals:
￿ Creation of two different training concepts for transfer-
ring evidence-based knowledge on dementia to partici-
pants of GP quality circles (randomization on the level of
the quality circles)
￿ Testing of contents and didactic materials with a large
number of GPs in terms of knowledge gain and (to some
extent) behavior-related changes
￿ Identification and description of
 content-related barriers, for example GPs' reluctance to
deal with the dementia syndrome
 technical barriers, for example the chosen media or e-
learning toolsBMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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The study results provide insights into how GPs can best
be trained in an evidence-based and decentralized way.
Methods/Design
The study involves a comparison of two dementia-related
training concepts:
￿ Concept A consists of a structured case discussion study
within the GPs' quality circle, moderated by a trainer. Par-
ticipants are required to prepare independently before-
hand by attending e-training sessions at a designated
Internet site ("blended-learning" approach). Training
"reminders" are regularly sent to increase the GPs' motiva-
tion.
￿ Concept B consists of a conventional face-to-face train-
ing in the GPs' quality circle with the same structured case
discussion as in concept A ("classical" approach).
In order to detect possible changes in the general condi-
tions (e.g. new guidelines of the health insurances, new
financial regulations for GPs), the study also includes a
control group consisting of other GPs who are given a
print out of the dementia guidelines only.
Hypotheses
It is assumed that the knowledge gain (KG) between t0
and t1 will be higher in concept A ("blended-learning"
approach) than in concept B. However this hypothesis
will be tested in a two-sided manner ("classical"
approach).
Primary and secondary outcomes of the WIDA trial
The study's primary outcome is to compare the effective-
ness of two different types of interventions, with the goal
of determining whether one of these concepts leads to
more effective transfer of knowledge than the other.
Secondary outcome involve
￿ possible changes in the behavior of GPs after interven-
tion
￿ utilization or non-utilization of e-learning tools (barrier
analysis)
￿ the acceptance of new learning tools and methods in
GPs' quality circles
Selection of outcomes
Primary outcome is the knowledge gain between pre- and
post-testing in the comparison of the two groups, assessed
via two standardized questionnaires circulated at times t0
(before the training) and t1 (after the training).
Secondary outcomes regard both general knowledge gain
(t1 and t2) and a comparison of the two groups at time t2.
Possible behavioral changes on the part of GPs are ascer-
tained with the help of four parameters taken from a sam-
ple of participants (t2) [4]. The information will be
gleaned from the IT systems used in the GPs' offices:
￿ parameter 1: frequency of dementia screenings by psy-
chometrical testing procedures in the medical practice,
determined through EBM figures (EBM = Einheitlicher
Bewertungsmaßstab  = standardized assessment factor),
stored in the accounting file
￿ parameter 2: frequency of diagnosis „dementia", deter-
mined through ICD codes
￿ parameter 3: frequency of prescription of selected anti-
dementives (cholinesterase inhibitors, Memantine, Pira-
cetam, Ginkgo-biloba compounds),
￿ parameter 4: characteristics of GPs' treatment, deter-
mined via EBM figures
Further steps are
￿ to assess use or non-use of additional e-learning tools in
study arm A, measured via questionnaires at t1 and t2
￿ to qualitatively analyze discussions in the quality circles
￿ to qualitatively analyze interviews carried out in a sam-
ple group of participants from both training approaches.
Schedule for training and evaluation
A time period of three to six months is scheduled for
recruiting GP quality circles and for attending two consec-
utive QC meetings (t0 and t1) (figure 1). Evaluation at
time t2 is scheduled six months or two quarters (± 4
weeks) after the face-to-face training on dementia (t1). The
evaluation and results can therefore be expected by late
2007.
Specification of research questions
Study population and selection criteria
The planned training primarily addresses general practi-
tioners, physicians, and specialists for internal medicine
also working as GPs. Therefore, the WIDA study should
orient its setting to the GP's environment as closely as pos-
sible. Quality circles will be recruited either by a letter to
QC moderators signed by the head of the study or through
personal contact. The plan is to recruit 174 GPs in approx-
imately 20 quality circles in North-Rhine Westphalia (see
estimation of number of cases). Willingness to participate
is considered a prerequisite for participation. In the event
that not enough GPs can be recruited, the search will beBMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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Flow chart training and evaluation Figure 1
Flow chart training and evaluation.BMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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extended to other quality circles which may also be
located in other regions or federal states.
Participation requirements
Participants in the study are required to participate in two
consecutive QC meetings. In the event that a physician
participates in more than one of the participating quality
circles, s/he is enlisted at the time of his/her first contact
with the study. An exchange with participants from other
quality circles is theoretically possible, yet improbable. In
the event that a participant is active in different circles,
his/her participation is defined in terms of the circle
where s/he was first introduced to the study.
Another requirement is the availability of Internet access
(either in the medical practice or at home). GPs without
internet access may participate, but their performance will
not be included in the analysis. The following parameters
will also be determined (table 1):
The interventions
After consent has been given by the QC moderators, all
participating QCs will be visited at time t0 by one or sev-
eral physicians working at the Competence Center for
General Practice and Outpatients' Health Care, Witten/
Herdecke-University. Having been informed of the study
goals and the time required for participation in the WIDA
study, the QC members will be invited to participate. After
filling out a declaration of consent, the participants' mas-
ter data are entered onto a data sheet. Next, all participat-
ing doctors receive a questionnaire to test their
knowledge. The questionnaire contains 20 multiple
choice questions on dementia. Internet access is also
checked by means of a standardized questionnaire. All
doctors in one participating QC are assigned to either
group A or B in the first QC meeting (t0) (figure 1). An
envelope containing the assignments will be opened by
the facilitating doctor at the end of the introductory ses-
sion; up to that time the envelope will remain closed.
Six months (± 4 weeks) after the intervention 13 partici-
pants from each group will be selected (t2). The aim is to
gather relevant data for measuring a potential behavioral
change by analyzing data from the doctor's IT. This data is
then transferred to a structured data sheet. In addition,
based on a semi-standardized check list, a qualitative
interview is conducted, documented in digital form and
transcribed later on (figure 1).
Specifics of study arm A
Having filled out the questionnaire (see above), partici-
pants are introduced to the e-learning tools (t0). They are
given the relevant internet address (URL), and informed
that a case discussion is scheduled for the next QC session
which calls for their independent study before the meet-
ing. The motivation to make use of the e-learning tools is
considered a key factor for the success of training concept
A.
Between the two training dates (t0-t1) all doctors partici-
pating in study arm A are provided with access to the
WIDA's new internet site. There participants can find the
latest evidence-based knowledge on dementia. The e-
learning tools include:
Table 1: Parameters to be ascertained
Quality Circles (QC)
Size of QC (estimated in advance by moderator)
Number of QC participants at t0 and t1
Number of QC participants actually participating in the study (t0 and t1 plus declaration of consent)
„Classical" Quality Circle or Practice Network
Interdisciplinary Quality Circle (yes/no)
Area of Medical Association (KVNO, KVWL)
Average number of QC meetings per year
Training on dementia/geriatric assessment within the past 6 or 12 months
Participants
Training on dementia/geriatric assessment within the past 6 or 12 months
Age
Sex
Internet user (yes/no*)
E-learning experience („Have you previously participated in a medical training via internet or CD-ROM?")
*excluding criterionBMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
Page 8 of 15
(page number not for citation purposes)
￿ the electronic version of the dementia guideline – both
in hypertext and pdf format
￿ two online case stories on dementia
￿ three testing modules on dementia allowing for the con-
secutive acquisition of CME credit points
￿ additional media for knowledge acquisition
Regular reminders as well as online support serve to
increase the general acceptance and use of the e-learning
tools. The technical aspects of the e-platform are described
elsewhere [88].
Reminders
E-mail reminders can support the use of electronic guide-
lines and web-based training (Online-CME) [46,48,72].
In order to enhance participants' motivation to use the
internet-based materials, training concept A makes use of
a maximum of five e-mail reminders/telephone calls/let-
ters (t0 - t1). Physicians receive the first reminder in the
week after the first training-related QC event. Reminders
can also be mailed in the form of a newsletter focusing on
dementia. Alternatively, the reminder can be sent via tele-
fax. All reminders follow a standard procedure, i.e. all par-
ticipants of group A receive the same information.
Support
In addition to the planned reminders, participants are
given an e-mail support address plus phone and fax
number in order to receive timely technical support (t0-t1)
(hotline installation). Discussion of further questions and
feedback is reserved for the second QC meeting; thus the
support does not include a content-related tutoring.
During the second QC meeting (t1), study arm A immedi-
ately starts with the structured case discussion. Following
that, participants are once again asked to fill out the ques-
tionnaire on dementia-related questions (20 multiple
choice questions). Simultaneously, the use or non-use of
the e-learning tools is checked by means of a second ques-
tionnaire. Subsequently, there is an open discussion of the
study, its educational content as well as its media.
Also, it is pointed out that participants will once again
receive the questionnaire after another six months (by
post). At the end of the second QC meeting, participants
will be provided with a printed handout.
Specifics of study arm B
After having agreed to participate in the study, physicians
learn that they will be trained on dementia in their next
QC meeting. At this second meeting (t1), GPs receive a
dementia-related training based on a slide presentation.
The training will then be followed by a structured case dis-
cussion similar to the one described above for study arm
A. This case discussion is also followed by the knowledge
test with 20 multiple choice questions, a general discus-
sion of the WIDA study and the reminder that the ques-
tionnaire will once again be sent to participants (by post)
in six months time. At the end of this QC session, partici-
pants receive a printed handout.
Control group without intervention
Having given their consent to participate in an anony-
mous test of their knowledge, the QC participants are
tested during the first QC meeting. Participants also
receive a printed version of the dementia guideline. Six
months later, participants again receive the questionnaire
on dementia per regular mail along with a questionnaire
pertaining to the frequency with which they used the
guideline. Data is gathered for the control group only at t0
and t2' (figure 1).
Development of the learning material
In the WIDA study, the scientific framework for the GP
training is an evidence-based guideline to the dementia
syndrome provided by two authors (HCV, MB) of Witten/
Herdecke University. The guideline has been updated
three times since its first publication in March 2001 (last
update: May 2005) [73]. It presents a condensed version
of international documents and studies adapted to the
German health care system [73]. The guideline also serves
as a basis for the DEGAM dementia guideline which is
presently being developed and approved.
In the context of the WIDA study adequate study materials
(printed short form of the dementia guideline) are devel-
oped and given to the participants. Also, a special internet
site is prepared for e-learning and containing online case
stories, CME modules as well as the guideline in hypertext
and pdf-format.
Statistics
Chi-Square test is used to analyze dichotomous and cate-
gorical variables. Mann-Whitney U Test is used for com-
paring continuous variables in independent groups. A p-
value <0.05 is considered to indicate a statistical signifi-
cance.
The evaluation is carried out as follows: differences
between the cumulative values of the pre-test question-
naire and those of the post-test questionnaire are deter-
mined. The distribution of these differences in each group
is analyzed by means of a T-test for statistical relevance.
Mean values and standard deviation from difference val-
ues are indicated. Additionally, a calculation via ANCOVA
model is planned. Calculation is carried out according to
an intention-to-treat (ITT) principle, i.e. all physicians areBMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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included in the analysis, even those who did not make use
of the alternative learning methods. A subgroup analysis
is planed for the participants of the blended learning
approach according to frequency of their internet use.
Randomization
Cluster randomization (RX) takes place at QC level. In
order to attain the aspired base of 87 participants per
group, we assume that it will be necessary to recruit 20
quality circles (see below). This should be a sufficient
number for safeguarding the compatibility of both
groups' participants (in terms of numbers, sex, age, etc). If
necessary, more quality circles can be included in the
study.
Stratified randomization was performed separately for
small and large quality circles where the cut-off was cho-
sen at 12 members per QC. Within each group block ran-
domization with variable block size (max. 6 per block)
was applied. Group allocation was then placed in sealed
opaque envelopes with consecutive numbering for each
stratum.
Measures against confounding
From a methodological point of view, the largest problem
of cluster-randomized studies is the risk of a selection bias
[74]. Even if the allocation of quality circles to the two
training groups is done randomly, physicians' inclusion
or exclusion cannot be completely controlled. The exclu-
sion of certain physicians might lead to structural inequal-
ity. Therefore, an a posteriori comparison of participants'
basic data will be carried out in both training groups.
Further undesired effects might occur due to health care-
related measures (such as campaigns). Therefore, a low-
threshold intervention is carried out in about ten addi-
tional quality circles (distribution/mailing of guideline in
printed form). Participants in these circles simultaneously
receive the knowledge-testing questionnaire and another
questionnaire concerning the use of the printed guideline.
It has been suggested that merely passive strategies for dis-
seminating and implementing new knowledge or new
guidelines are largely ineffective [48]. However, the effort
needed to study such an additional control group with
low threshold intervention seems justified in order to
map disturbance variables.
Consideration of drop-outs
Evaluation of the study's primary inquiry is done accord-
ing to the ITT principle (see above), where all physicians
are evaluated regardless of mode and degree of their actual
participation in the training course to which they are pri-
marily assigned. Withdrawal from the study is possible if
the declaration of consent is revoked. In all cases, the data
collected up to the point of exclusion or drop-out is eval-
uated.
Reflections of outcome parameters
Primary outcome: knowledge gain
Knowledge gain is measured by employing a multiple
choice questionnaire on two levels:
1. It was first used in a pilot test of ten physicians partici-
pating in the Witten/Herdecke University's quality circle.
2. After revising the 20 items with 5 characteristics each,
the questionnaire was used in the context of the "Demen-
tia in General Medicine" (IDA) initiative by the AOK
Bavaria between August and November 2005 [75,76]. In
this project, 132 GPs were trained in Bavaria and the ques-
tionnaire was subsequently employed. Here, a significant
knowledge gain of 4.0 ± 2.6 questions (confidence inter-
val 3.6 – 4.5, p < 0.001) was identified. The comparison
of two different training groups displayed a difference of
mean values of 3.1 ± 2.1 (p < 0.001). In both cases, this
resulted in an effect size of 1.5 (Cohen's d) [76]. The thus
evaluated questionnaire will be used in the WIDA study.
However, an effect size of 1.5 appears to be too optimistic.
A current US study compared an online training with a
classical face-to-face training and assumed an effect size of
0.75 [62]. Extensive investigation did not identify directly
comparable research on the effects of a blended-learning
concept which could have served as a basis for sample size
calculation. Therefore the WIDA study assumes a conserv-
atively assessed medium effect size of 0.5. Using this effect
size, and assuming standard error assumptions (α = 5%,
power = 80%). The target sample size is 64 per group, or
128 in total (G-Power software).
This sample size allows us to check whether the two train-
ing concepts differ by about 0.5 SD which corresponds to
about one (or more) correctly answered question. In case
of a non significant result we could be about 80% certain
(power) that the difference between both approaches is
not more than one correct question. This means that both
approaches are roughly comparable (non-inferiority)
while approach A (blended-learning) will maybe require
fewer resources.
Consideration of the design effect and calculation of the drop-out 
rate
The so-called design effect (DE) is assessed according to:
DE = 1 + ICC (m-1) with ICC matching the intra-cluster
correlation coefficient m of the average cluster size. The
average cluster size (corresponding to the average number
of participants in a QC) is assumed to be 10. For the ICC,
values between 0.01 and 0.02 for studies on patients are
given in the literature [82]. For intervention studies on
physicians, the assumed values lie mostly between 0.02BMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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and 0.1 [81,83,84]. With our purposes, a value of 0.04 is
assumed. This results in a design effect of: 1 + 0.04 (10-1)
= 1.36.
Thus the sample size assessment given above (n = 128)
should be multiplied by this factor. This results in a sam-
ple size of 174 test persons.
It is furthermore assumed that approximately 15% of QC
participants will refuse participation or will not show up
due to schedule conflicts. Therefore, to achieve the desired
sample size of 174, 20 quality circles with an average of 10
participants or a total of 200 physicians are necessary.
Secondary outcomes: behavior modification
An informal interviewing of doctors teaching at Witten/
Herdecke University revealed that they were extremely
reluctant to provide patient data for research purposes. It
must be assumed that GPs without a university affiliation
will show an ever greater reluctance to provide data from
their medical practice. Therefore, we have refrained from
considering changes in prescription behavior as a primary
goal parameter. Based on the rather low prevalence (an
estimated 12 dementia patients per medical practice per
quarter with a very broad distribution, see below) it also
does not seem feasible – due to limited duration of study
and resources – to collect patient data directly for the pur-
pose of comparing the effectiveness of the two training
concepts. Yet, in order to receive at least an indirect
impression of what happens at the level of GPs' behavior,
an attempt is made to visit 13 medical practices (= 15% of
all participants) per group. The reason for doing this is
1. to extract treatment-relevant data from the physicians
files
2. to conduct qualitative interviews with GPs.
The 13 control samples are selected from each group
according to their informed consent. In the event that a
GP refuses further participation at this point, the attempt
is made to find out why. Another participating GP is then
selected.
The evaluation of the behavioral modification parameters
is based on the following assumptions:
￿ Average number of patients per GP practice per quarter
= 1000 (data provided by the Medical Association of
Westfalen-Lippe as of September 20, 2005).
￿ Average portion of retirees in GPs' practices: 35% (data
provided by the Medical Association of Westfalen-Lippe,
as of September 20, 2005).
￿ Prevalence of dementia in Germany in the 65+ age
group: 7.2%, equivalent to nearly one million patients
[12].
￿ Incidence of dementia in Germany in the 65+ age group:
1.9%, equivalent to approximately 230,000 incidences
per annum [12].
￿ Roughly 83,000 patients received anti-dementives
whose use is considered evidence-based (as of 2003) [77].
This means that about 8.3% of all dementia patients
received recommended medication. This corresponds to
information given in literature which also states that the
prescription frequency of recommended anti-dementives
is 9% for Germany [4,20]. (Note: This does not suggest
that one million dementia patients should be treated with
anti-dementives. As a matter of course, a very tight medi-
cal indication and existing contra-indications imply that
only a fraction of dementia patients can be considered for
drug therapy.)
￿ About 440,000 patients have been treated with anti-
dementives which must be considered questionable with
respect to effectiveness (as of 2003) [77]. This corresponds
to 44% of all dementia patients.
￿ The invoicing of patients covered by compulsory health
insurance, is based on the currently valid standardized
assessment factor (EBM 2000plus), which considers revi-
sions made by the assessment commission (valid as of
April 1, 2005) as well as revisions of § 87, paragraph 3,
SGB V (effective as of July 1, 2005).
￿ The billing of patients covered by a private health insur-
ance is based on the January 2002 tariff for physicians
(GOÄ).
The analysis of behavior modification data is carried out
as follows:
￿ Summarizing of collected data (t2) from participating
medical practices of groups A and B in the four quarters
prior to intervention; then generation of the arithmetic
average. The average of four quarters is used in order to
limit possible distortion (e.g. due to the introduction of
EBM 2000plus).
￿ Summarizing of collected data (t2) from all participating
practices of groups A and B in the two quarters after inter-
vention and generation of the arithmetic average. Due to
the maximum duration of the study, only two quarters are
averaged.
￿ Comparison of average values.BMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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￿ Comparison with the data provided by the Medical
Association of Westfalen-Lippe to the extent that it is
available for the period of reference.
Addenda: screening
Based on an average of 350 patients over 65 years per
quarter, a dementia prevalence of 7.2% in the overall pop-
ulation and assuming that only 50% of all dementia
patients undergo GP treatment, we calculate an average of
12 dementia patients per GP. In spite of indications point-
ing to a possibly higher prevalence in GP practices
[33,78], this estimate is intentionally a conservative one.
A survey of British GPs reveal that psychometric tests are
used in only 15% of all cases in which the patient is
believed to be suffering from dementia [79]. Because this
data is missing for Germany, we use these 15% as a refer-
ence value. Assuming an average of per GP and quarter, it
is therefore estimated that a screening is conducted on
only two patients. An increase in screening can be
expected after dementia training.
Addenda: prescription of anti-dementives
With 12 dementia patients per quarter, approximately 8%
or one patient would receive a recommended drug while
44% (nearly 5 patients) would receive a non-recom-
mended anti-dementive [77].
In order to compare prescription frequency of anti-
dementives before and after the training sessions, a quo-
tient is created and compared; the expectation is that the
quotient will increase:
Aprä + : recommended anti-dementives prior to interven-
tion
A
A
A
A
pr
pr
post
post
+
−
<
+
−
Table 2: Dimensions of knowledge translation (knowledge gain; behavior modification)
Quantitative parameters Qualitative parameters (following a structured interview 
guideline)
number of participants, response of questionnaires, use of training 
measures
• questions regarding user behavior
• identification of barriers
knowledge gain measured by two questionnaires (pre- and post test) • subjective evaluation of knowledge gain
"behavior modification screening" gathered by EBM2000plus (GOÄ):
• (03313 orientation survey of psychopathological status)
• 03314 (857) mental tests
• 03341 GP-geriatric basic assessment
investigation at t2: assessment of 4 quarters before and 2 quarters 
after intervention
• self-evaluation of behavior
• identification of barriers
„behavior modification diagnosis/differential diagnosis" assessed via six 
figures of ICD-10-GM 2005: F00, F01, F02, F03, F07, G32, R54
data gathered at t2: assessment of 4 quarters before and 2 quarters after 
intervention
• question whether diagnostic behavior has changed
• identification of barriers
„behavior modification therapy" ascertained via prescriptions of anti-
dementives*:
• cholinesterase inhibitors
• memantine
• ginkgo biloba compounds
• piracetam
investigation at t2: assessment of 4 quarters before and 2 quarters 
after intervention
• identify whether there is an increase in the prescription of evaluated 
anti-dementives (e.g. cholinesterase inhibitors, memantines) and 
whether there is a decrease in the prescription of untested or unreliable 
anti-dementives (e.g. ginkgo biloba compounds, piracetam)
• question regarding future drug therapy
• identification of barriers
„behavior modification treatment" gathered by EBM2000plus:
03001 coordination of GP-related care
03002 coordination of GP-related care in nursing homes
21230 continuous co-care in the domestic environment
21231 continuous co-care in a nursing facility
21232 psychiatric treatment
investigation at t2: assessment of 4 quarters before and 2 quarters after 
intervention
• question regarding prescription of non drug-related therapy
• question regarding support groups for family members
• interaction with patients and family members when patient is 
suspected to suffer from dementia and when the diagnosis has been 
confirmed
• identification of barriers
* Based on the most frequent prescriptions in Germany 2003 [77]BMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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Aprä - : non-recommended anti-dementives prior to inter-
vention
Apost + : recommended anti-dementives following inter-
vention
Apost - : non-recommended anti-dementives following
intervention
Addenda: Qualitative analysis
Qualitative interviews with 13 participating physicians
per group take place at t2. Table 2 presents a "correlation"
of quantitative and qualitative parameters.
Addenda: Internet use
Internet use is ascertained anonymously with the help of
a "counter" and questionnaires administered at t1 and t2.
A personalized tracking of internet users was not per-
formed:
1. for reasons of privacy and data protection (see data pro-
tection)
2. because the recruitment of GPs in other projects
revealed that personalized tracking would be viewed
apprehensively and lead to a massive reduction in the
number of participants or a rejection of e-learning tools.
For this reason there is no personalized tracking of partic-
ipating GPs. Instead, a counter at the study's website reg-
isters the number of site visits. It is assumed that third
parties will not use the WIDA site since URL information
will be restricted to participants until completion of the
study. In addition to user data collected in this manner,
participants will be asked about length and intensity of
their e-training sessions in the questionnaire. In this way
a correlation between duration of use and outcome can be
expected.
Data management
Data collection
Collection of GP data at the time of the study's inception
(t0) and at t1 and t2 is per hard copy. Postage-paid enve-
lopes are provided so that the GPs will send back the ques-
tionnaire at t2. Selected medical practices send their data,
which are identified via differentiated search strategies
and transferred via BDT-interface in anonymous form, to
a storage medium. In the event that this is technically not
possible, the office staff provides the necessary data by fill-
ing out a form. Office personnel are briefed by UWH
employees in advance with respect to the type of data
required. This ensures that patient files cannot be accessed
by UHW employees.
Scheduling of data collection
Various methods of data collection are used in this study.
Questionnaires are filled out by the participating physi-
cians. There is also an evaluation of data from the web-
server which provides for online learning.
The WIDA study foresees the following investigation
schedule:
￿ t0: acceptance of GPs to the study (first study-related QC
meeting)
￿ between t0 and t1: data on internet use (group A only)
￿ t1: after approximately three months (second study-
related QC meeting)
￿ t2: 6 months (± 4 weeks) after t1 (control group: t2')
The amount of documentation required by GPs is kept
low so as not to jeopardize the participants' motivation.
Data protection
For the various phases of processing patient-related data
(storage, modification, transfer, deletion and use) and
data security, the valid directives of the Federal Data Secu-
rity Act (Bundesdatenschutzgesetz, BDSG) and the various
special regulations (e.g. SGB V, SGB VII, SGB IX) for data
processing shall be complied with and the necessary tech-
nical and organizational measures taken. § 40 – "process-
ing and use of person-related data by research
institutions" – clause 2 of the Federal Data Protection Act
(BDSG) states:
„Person-related data must be rendered anonymous as
soon as the research purpose allows for it. Up to this
point, any attributes which make it possible to assign par-
ticular personal or factual circumstances to a certain or
ascertainable person must be stored separately. Such
attributes may only be assigned to their owner in as much
as necessitated by the research purpose."
Accordingly all research-relevant data is saved anony-
mously. Person-related data is kept separately only if this
data is required for establishing contact and for corre-
spondence.
Premature termination of the study
Due to close-meshed monitoring, recruiting problems or
problems of data quality can be detected at an early stage.
It is therefore possible to take appropriate counteractive
measures. For this reason premature termination of the
study due to insufficient recruitment is unlikely. The same
holds true for premature termination due to new scientific
insights. Moreover, premature termination due to earlyBMC Health Services Research 2007, 7:92 http://www.biomedcentral.com/1472-6963/7/92
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results regarding the superiority of one training concept is
also not likely since training will be completed long
before first trends will become recognizable. In the event
that the study must be terminated prematurely due to
unforeseeable reasons, the data collected up to that point
will nonetheless be published. Any decision regarding a
possible premature termination of the study lies in the
responsibility of the investigators in consultation with the
Federal Ministry of Education and Research (BMBF).
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